The company's next-generation sequencing-based test is used to aid the detection of cancers in patients with indeterminate lesions.

A world-first antiviral treatment has been developed for human papillomaviruses (HPVs) which can lead to mouth cancer.

Cedars-Sinai investigators led an update of staging guidelines for HPV-positive throat cancer—now more common in the U.S.

Head and neck cancers, encompassing growths in the throat, larynx, nose, and mouth, account for 4% of cancers worldwide. Key ...